Bladder Morphology Using 2 Different Catheter Designs
1 other identifier
interventional
3
1 country
1
Brief Summary
Demonstrate and compare the 3D morphology of the bladder wall in full and drained states with 2 different kinds of bladder catheters in place. (Foley Catheter vs. Cystosure Catheter)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2017
CompletedStudy Start
First participant enrolled
April 1, 2017
CompletedFirst Posted
Study publicly available on registry
April 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedApril 12, 2017
April 1, 2017
1 month
March 30, 2017
April 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bladder shape after emptying
Bladder shape after emptying using both catheters will be assessed. The 3D reconstructed images will be compared to determine if there are any differences in bladder shape in full and empty states between the 2 catheter types.
1 month
Study Arms (1)
Arm 1
OTHERWomen who agree to participate will undergo a standard high resolution, thin slice pelvic floor static/dynamic MRI study, first with a full bladder, and after the bladder is emptied. Bladder filling and drainage will be performed sequentially, using each of the 2 catheter types (Cystosure Urinary Access Catheter and Foley Catheter). During bladder emptying, a cine video scan will be taken at the midsagittal plane to show the dynamics of the bladder fluid and walls during emptying. Each subject will serve as their own control. Interventions are listed in the "Interventions" Section.
Interventions
1. Demonstrate the 3D bladder wall anatomy with 300 cc of fluid infused with each of the following bladder drainage mechanisms 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 2. Compare the fluid flow pattern during bladder drainage for 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 3. Compare the 3D bladder wall anatomy after emptying the bladder with 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B)
1. Demonstrate the 3D bladder wall anatomy with 300 cc of fluid infused with each of the following bladder drainage mechanisms 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 2. Compare the fluid flow pattern during bladder drainage for 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 3. Compare the 3D bladder wall anatomy after emptying the bladder with 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B)
Eligibility Criteria
You may qualify if:
- Pelvic Floor Institute patients aged between 21 and 70 years of age, who are able to speak and understand English, who are not currently pregnant, or had a pregnancy in the previous 6 months.
You may not qualify if:
- Women with claustrophobia or any contraindication to undergoing an MRI scan will be excluded. Similarly, women with hip, knee, or shoulder replacements will be excluded because of the need for urethral catheterization. Women with significant mitral valve prolapse will also be excluded for the same reason. Women with history of 3 or more culture-documented UTIs over the last 12 months will be excluded. Women who are unable or unwilling to give informed consent will also be excluded. Women who are unable to tolerate 300 cc of fluid in the bladder will be excluded. Women with a nitrite-positive urinalysis at the time of study enrollment will be excluded until they can demonstrate a negative urine culture.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Pelvic Floor Institutelead
- Cystosurecollaborator
- Innovative Research Inc.collaborator
Study Sites (1)
The Pelvic Floor Institute
Tampa, Florida, 33609, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lennox Hoyte, MD, MSEECS
The Pelvic Floor Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 30, 2017
First Posted
April 11, 2017
Study Start
April 1, 2017
Primary Completion
May 1, 2017
Study Completion
June 1, 2017
Last Updated
April 12, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share